Are Wall Street Analysts Bullish on Allstate Stock?
Allstate (ALL) shares have gained 25.3% over 52 weeks versus 20.4% for the S&P 500 and are up 25.6% YTD versus 13.7%. After Q2 2026 results on Aug. 5, adjusted EPS of $8.99 beat consensus; net investment income rose to $1.0B and catastrophe losses fell. Analysts expect 2026 adjusted EPS of $33.92. JPMorgan raised its price target to $292; mean target $273.83.
How this was made
%252FAllstate%252520Corp%252520location%252520-%252520by%252520Brett_Hondow%252520via%252520iStock.jpg&w=3840&q=75)
The 30-second read
Why it matters
Traders may use the JPMorgan target hike and the described underwriting/catastrophe improvements to gauge sentiment, but the article does not introduce new guidance beyond what was already reported in the Q2 results.
Market read
Analyst sentiment is framed as slightly less bullish than three months ago, but still Moderate Buy, with a specific PT increase after Q2 beats.
What to watch
The article notes FY2026 adjusted EPS is expected to decline 2.6% year over year, which can limit multiple expansion even with better-than-expected quarter drivers.
Background
The piece summarizes Allstate’s recent performance versus indices, then ties it to Q2 2026 results and current sell-side consensus.
Ticker impact
Allstate shares rallied after Q2 2026 results and JPMorgan raised its price target to $292 with an Overweight rating.
Bias toward continued support on dips, but upside may be capped by the already-strong post-results run-up and only moderate consensus.
The article cites specific Q2 EPS and underwriting/catastrophe drivers plus a dated analyst price-target increase, but it is still an analyst-rating framing rather than new company guidance.
Market effects
Positive read-through for property-casualty insurers if underwriting and catastrophe-loss trends persist.
Primarily US large-cap insurance sentiment; limited direct regional spillover described.
No explicit global macro or cross-border catalyst mentioned.
Counterpoint
Despite the PT raise, the consensus mix includes equal numbers of Holds and Strong Sells, suggesting valuation or forward earnings risk remains.
Key entities
- companyAllstate Corporation
US property and casualty insurer discussed as the subject of the analyst sentiment and post-earnings performance.
- financial_institutionJPMorgan
Raised Allstate’s price target to $292 and maintained an Overweight rating, per the article.
